A group of 12 state attorneys general have signed a letter encouraging the U.S. Drug Enforcement Administration (DEA) to reschedule cannabis to Schedule III...
An Australian study of medicinal cannabis use indicates distinct demographic preferences between legally prescribed tetrahydrocannabinol (THC) and cannabidiol (CBD) products.A group of researchers primarily...